Successful treatment of unresectable recurrent programmed death ligand 1 moderately‐expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy
Taku Fujimura(Université Paris Cité), Setsuya Aiba(Tohoku University), Yumi Kambayashi(Tohoku University), Kayo Tanita(Tohoku University), Yota Sato(Tohoku University), Akira Hashimoto(Tohoku University), Hisayuki Tono(Tohoku University), Chunbing Lyu(Tohoku University), Toshiya Takahashi(Tohoku University)
Cited by 1
Related Papers
Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells
|Infection and Immunity|2005|361
Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34
|British Journal of Dermatology|1992|235
Notch signaling: Its role in epidermal homeostasis and in the pathogenesis of skin diseases
|Journal of Dermatological Science|2007|163